United States · FDA National Drug Code directory
FENOFIBRATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70756-215_4a13e20b-6a21-4d45-a159-a2add4ce215e
- Product NDC
- 70756-215
- Form
- TABLET
- Composition / generic term
- FENOFIBRATE
- Labeler
- Lifestar Pharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200910
- Source listing expiry
- 20261231
Source-listed ingredients
- FENOFIBRATE — 160 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (70756-215-51) · 70756-215-51
- 90 TABLET in 1 BOTTLE (70756-215-90) · 70756-215-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →